Adiposogenital dystrophy risk factors
|
Adiposogenital dystrophy Microchapters |
|
Differentiating Adiposogenital dystrophy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Adiposogenital dystrophy risk factors On the Web |
|
American Roentgen Ray Society Images of Adiposogenital dystrophy risk factors |
|
Risk calculators and risk factors for Adiposogenital dystrophy risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD
Overview
Common risk factors in the development of adiposogenital dystrophy are male sex, hypothalamic tumors, infectious, autoimmune, chemical, traumatic, and radiation insults to the brain.
Risk factors
Risk factors for adiposogenital genital dystrophy include:
- Tumors of the hypothalamus and pituitary[1]
- Male sex [2]
- Radiation [3] [4]
- Autoimmune disease [5] [6]
- Traumatic brain injuries [7] [8]
- Infections[9] [10]
- Chemotherapy [11] [12]
- Deep brain stimulation [13] [14]
References
- ↑ Babinski-fröhlich syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852§ionid=49517244
- ↑ Babinski-fröhlich syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852§ionid=49517244
- ↑ Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Hypopituitarism after radiotherapy for extracranial head and neck cancers. Head Neck. 2008 Sep;30(9):1182-92.
- ↑ Sfeir JG, Kittah NEN, Tamhane SU, Jasim S, Chemaitilly W, Cohen LE, Murad MH. Diagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers. J Clin Endocrinol Metab. 2018 Aug 01;103(8):2785-2793.
- ↑ Molina A, Mañá J, Villabona C, Fernández-Castañer M, Soler J (2002). "Hypothalamic-pituitary sarcoidosis with hypopituitarism. Long-term remission with methylprednisolone pulse therapy". Pituitary. 5 (1): 33–6. doi:10.1023/a:1022153401880. PMID 12638724.
- ↑ Belojevic G, Maric-Zivkovic J (2005) Sarcoidosis and obesity. Med Pregl 58(Suppl 1):44–45 Medline
- ↑ Krahulik D, Zapletalova J, Frysak Z, Vaverka M. Dysfunction of hypothalamic-hypophysial axis after traumatic brain injury in adults. J Neurosurg. 2010 Sep;113(3):581-4.
- ↑ Tudor RM, Thompson CJ. Posterior pituitary dysfunction following traumatic brain injury: review. Pituitary. 2019 Jun;22(3):296-304.
- ↑ Aulakh R, Chopra S (2018). "Pediatric Tubercular Meningitis: A Review". J Pediatr Neurosci. 13 (4): 373–382. doi:10.4103/JPN.JPN_78_18. PMC 6413593. PMID 30937075.
- ↑ Babinski-fröhlich syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852§ionid=49517244
- ↑ van Iersel L, Li Z, Srivastava DK, Brinkman TM, Bjornard KL, Wilson CL, Green DM, Merchant TE, Pui CH, Howell RM, Smith SA, Armstrong GT, Hudson MM, Robison LL, Ness KK, Gajjar A, Krull KR, Sklar CA, van Santen HM, Chemaitilly W. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. J Clin Endocrinol Metab. 2019 Dec 01;104(12):6101-6115.
- ↑ Chemaitilly W, Armstrong GT, Gajjar A, Hudson MM. Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation. J Clin Oncol. 2016 Dec 20;34(36):4315-4319.
- ↑ Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Kotzd CM, Billington CJ; et al. (2005). "Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery". Parkinsonism Relat Disord. 11 (4): 247–52. doi:10.1016/j.parkreldis.2005.01.006. PMID 15878586.
- ↑ Romito LM, Scerrati M, Contarino MF, Iacoangeli M, Bentivoglio AR, Albanese A (2003) Bilateral high frequency subthalamic stimulation in Parkinson’s disease: long-term neurological follow-up. J Neurosurg Sci 47:119–128 Medline